SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The primate lentivirus auxiliary protein Vpx counteracts an unknown restriction factor that renders human dendritic and myeloid cells largely refractory to HIV-1 infection. Here we identify SAMHD1 as this restriction factor. SAMHD1 is a protein involved in Aicardi-Goutières syndrome, a genetic encephalopathy with symptoms mimicking congenital viral infection, that has been proposed to act as a negative regulator of the interferon response. We show that Vpx induces proteasomal degradation of SAMHD1. Silencing of SAMHD1 in non-permissive cell lines alleviates HIV-1 restriction and is associated with a significant accumulation of viral DNA in infected cells. Concurrently, overexpression of SAMHD1 in sensitive cells inhibits HIV-1 infection. The putative phosphohydrolase activity of SAMHD1 is probably required for HIV-1 restriction. Vpx-mediated relief of restriction is abolished in SAMHD1-negative cells. Finally, silencing of SAMHD1 markedly increases the susceptibility of monocytic-derived dendritic cells to infection. Our results demonstrate that SAMHD1 is an antiretroviral protein expressed in cells of the myeloid lineage that inhibits an early step of the viral life cycle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, sterile alpha motif and HD domain 1 (SAMHD1) inhibits reverse transcription by depleting the cellular pool of deoxynucleotide triphosphates [63,64]”
From HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread (2022) · cites this paper as [63]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This approach was necessary because PU.1 is the master transcriptional regulator necessary for macrophage differentiation and silencing PU.1 prior to infection results in a change in the cellular phenotype that causes resistance to HIV infection72,73.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [72]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Neil, S. J. D., Zang, T., & Bieniasz, P. D. (2008) · Nature · doi:10.1038/nature06553 · Cited by 1,902
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Rice, G. I., Bond, J., Asipu, A., Brunette, R. L., Manfield, I. W., Carr, I. M., Fuller, J. C., Jackson, R. M., Lamb, T., Briggs, T. A., et al. (2009) · Nature Genetics · doi:10.1038/ng.373 · Cited by 689
A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells
Manel, N., Hogstad, B., Wang, Y., Levy, D. E., Unutmaz, D., & Littman, D. R. (2010) · Nature · doi:10.1038/nature09337 · Cited by 427
Sobhian, B., Laguette, N., Yatim, A., Nakamura, M., Levy, Y., Kiernan, R., & Benkirane, M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.04.012 · Cited by 381
Self-citationBlanchet, F. P., Moris, A., Nikolic, D. S., Lehmann, M., Cardinaud, S., Stalder, R., Garcia, E., Dinkins, C., Leuba, F., Wu, L., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.04.011 · Cited by 295
Self-citationImmunoaffinity Purification of Mammalian Protein Complexes
Nakatani, Y., & Ogryzko, V. (2003) · Methods in Enzymology · doi:10.1016/s0076-6879(03)70037-8 · Cited by 283
DCs and NK cells: critical effectors in the immune response to HIV-1
Altfeld, M., Fadda, L., Frleta, D., & Bhardwaj, N. (2011) · Nature Reviews Immunology · doi:10.1038/nri2935 · Cited by 216
Srivastava, S., Swanson, S. K., Manel, N., Florens, L., Washburn, M. P., & Skowronski, J. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000059 · Cited by 209
Cited by
Items 401–500 of 1,001
HIV-1 mutates to evade IFITM1 restriction
Ding, S., Pan, Q., Liu, S., & Liang, C. (2014) · Virology · doi:10.1016/j.virol.2014.01.020 · Cited by 44
“…polypeptide-like 3G), TRIM5α (Tripartite motif-containing protein 5α), tetherin, SAMHD1 (SAM domain and HD domain-containing protein 1) and Schlafen 11 (Hrecka et al., 2011; Laguette et al., 2011; Li et al., 2012; Neil et al., 2008; Sadler and Williams, 2008; Stremlau et al., 2004).”
Mechanisms underlying HIV-1 Vpu-mediated viral egress
Roy, N., Pacini, G., Berlioz‐Torrent, C., & Janvier, K. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00177 · Cited by 44
“BST2 is localized at the plasma membrane (PM) in cholesterol–rich microdomains (rafts) and in intracellular compartments such as the TGN as well as early and recycling endosomes (Kupzig et al., 2003; Masuyama et al., 2009).”
BackgroundPortilho, D. M., Fernandez, J., Ringeard, M., Machado, A. K., Boulay, A., Mayer, M., Müller-Trutwin, M. C., Beignon, A., Kirchhoff, F., Nisole, S., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.12.039 · Cited by 46
“DCs were 2-fold less permissive than PBLs to HIV-1 infection (12.0% ± 6.9% versus 24.1% ± 8.7% infected cells, n = 4), as reported in the literature (Berger et al., 2011; Laguette et al., 2011).”
InfluentialSelf-citationFunctional proteomic atlas of HIV infection in primary human CD4+ T cells
Naamati, A., Williamson, J. C., Greenwood, E. J. D., Marelli, S., Lehner, P. J., & Matheson, N. J. (2019) · eLife · doi:10.7554/elife.41431 · Cited by 48
CARs and beyond: tailoring macrophage-based cell therapeutics to combat solid malignancies
Abdin, S. M., Paasch, D., Morgan, M. A., & Lachmann, N. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002741 · Cited by 49
Increasing intracellular dNTP levels improves prime editing efficiency
Liu, P., Ponnienselvan, K., Nyalile, T., Oikemus, S., Joynt, A. T., Iyer, S., Kelly, K. L., Guo, D., Kyawe, P. P., Vanderleeden, E., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02405-x · Cited by 46
“SAMHD1 is a deoxynucleotide triphosphohydrolase that maintains low dNTP levels in cells that are not undergoing DNA replication, which restricts infection by retroviruses 31,32 .”
Su, B., Xu, K., Lederle, A., Peressin, M., Biedma, M. E., Laumond, G., Schmidt, S., Decoville, T., Proust, A. M., Lambotin, M., et al. (2012) · Blood · doi:10.1182/blood-2012-03-418913 · Cited by 45
Influence of Common Mucosal Co‐Factors on HIV Infection in the Female Genital Tract
Ferreira, V. H., Kafka, J. K., & Kaushic, C. (2014) · American Journal of Reproductive Immunology · doi:10.1111/aji.12221 · Cited by 51
Effects of Cellular Activation on Anti-HIV-1 Restriction Factor Expression Profile in Primary Cells
Raposo, R. A. S., Abdel‐Mohsen, M., Bilska, M., Montefiori, D. C., Nixon, D. F., & Pillai, S. K. (2013) · Journal of Virology · doi:10.1128/jvi.02128-13 · Cited by 43
“SAMHD1 was recently shown to inhibit HIV and SIV infection in quiescent CD4 T cells (4, 5) and myeloid cells (6, 7) by eliminating the intracellular pool of deoxynucleoside triphosphates (dNTPs) required for viral cDNA production during reverse transcription.”
BackgroundSulforaphane Inhibits HIV Infection of Macrophages through Nrf2
Furuya, A. K. M., Sharifi, H. J., Jellinger, R. M., Cristofano, P., Shi, B., & de Noronha, C. M. C. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005581 · Cited by 44
Jeong, G. U., Park, I.-H., Ahn, K., & Ahn, B.-Y. (2016) · Virology · doi:10.1016/j.virol.2016.05.001 · Cited by 44
“It is not surprising that HBV, which infects and replicates in quiescent hepatocytes and in DMSO-treated hepatoma cells, is quite sensitive, perhaps more sensitive than HIV-1, to the restriction imposed by SAMHD1.”
BackgroundInfluentialEpithelium-innate immune cell axis in mucosal responses to SIV
Shang, L., Duan, L., Perkey, K., Wietgrefe, S. W., Zupancic, M., Smith, A. J., Southern, P. J., Johnson, R. P., & Haase, A. T. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.62 · Cited by 49
Impairment of the type I interferon response by HIV-1: Potential targets for HIV eradication
Sandstrom, T. S., Ranganath, N., & Angel, J. B. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.04.004 · Cited by 50
Ahmad, F., Mishra, N., Ahrenstorf, G., Franklin, B. S., Latz, E., Schmidt, R. E., & Bossaller, L. (2017) · AIDS · doi:10.1097/qad.0000000000001693 · Cited by 47
“As HIV-1 does not produce Vpx to counteract the viral restriction factor SAM domain and HD domain-containing protein1 [42], monocytes productively infected by HIV-1 are likely”
BackgroundOh, C., Ryoo, J., Park, K., Kim, B., Daly, M. B., Cho, D.-Y., & Ahn, K. (2018) · Scientific Reports · doi:10.1038/s41598-017-18308-8 · Cited by 50
Hsiao, F., Frouard, J., Gramatica, A., Xie, G., Telwatte, S., Lee, G. Q., Roychoudhury, P., Schwarzer, R., Luo, X., Yukl, S. A., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008450 · Cited by 48
“As a complementary approach to determine whether SAMHD1 plays a role in infection restriction in the CD127+ Tm cells, we abrogated its activity with Vpx, an accessory protein from SIV and HIV-2 that degrades SAMHD1 [17, 18].”
SUMOylation of SAMHD1 at Lysine 595 is required for HIV-1 restriction in non-cycling cells
Martinat, C., Cormier, A., Tobaly-Tapiero, J., Palmic, N., Casartelli, N., Mahboubi, B., Coggins, S. A., Buchrieser, J., Persaud, M., Diaz‐Griffero, F., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24802-5 · Cited by 45
Self-citationTang, Y.-D., Lei, N., Zhu, C., Shen, N., Yang, F., Fu, X.-Q., Wang, Y., Fu, L.-H., Wang, J., Lin, Y., et al. (2014) · Journal of Virology · doi:10.1128/jvi.01379-14 · Cited by 43
Banga, R., Procopio, F. A., Lana, E., Gladkov, G. T., Roseto, I. C., Parsons, E. M., Lian, X., Armani-Tourret, M., Bellefroid, M., Gao, C., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.08.020 · Cited by 50
“…low frequency of DCs, scarce availability of tissue DCs, and therefore the high reliance on experiments performed either on blood DCs or on in-vitro-derived DCs. 31–33 However, the conclusions proposed on the basis of in vitro generated DCs might not totally reflect the complexity of DCs in vivo.”
Metabolic immunity against microbes
Kreimendahl, S., & Pernas, L. F. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.10.013 · Cited by 48
Zhang, C., de Silva, S., Wang, J., & Wu, L. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037477 · Cited by 47
“Furthermore, Vpx of SIVmac251 and HIV-2 ROD from this clade have been demonstrated to degrade human SAMHD1 [3,4].”
BackgroundInfluentialCD169-Dependent Cell-Associated HIV-1 Transmission: A Driver of Virus Dissemination
Gummuluru, S., Ramirez, N.-G. P., & Akiyama, H. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu442 · Cited by 47
Macrophages in Progressive Human Immunodeficiency Virus/Simian Immunodeficiency Virus Infections
DiNapoli, S. R., Hirsch, V. M., & Brenchley, J. M. (2016) · Journal of Virology · doi:10.1128/jvi.00672-16 · Cited by 43
Seamon, K. J., Bumpus, N. N., & Stivers, J. T. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00986 · Cited by 42
IFN-ε protects primary macrophages against HIV infection
Tasker, C., Subbian, S., Gao, P., Couret, J., Levine, C., Ghanny, S., Soteropoulos, P., Zhao, X., Landau, N. R., Lu, W., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.88255 · Cited by 49
“Consistent with previous findings on HIV restriction of SAMHD1 (51, 59), the degree of HIV infection was significantly higher in PMA-differentiated, SAMHD1 knockdown THP1 cells than cells with SAMHD1.”
ResultReshaping of the Dendritic Cell Chromatin Landscape and Interferon Pathways during HIV Infection
Johnson, J. S., Lucas, S. Y., Amon, L. M., Skelton, S., Nazitto, R., Carbonetti, S., Sather, D. N., Littman, D. R., & Aderem, A. A. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.01.012 · Cited by 46
“This is largely due to DCs expressing high levels of the restriction factor, SAMHD1, a nucleotide phosphohydrolase that prevents reverse transcription of retroviruses (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundCattin, A., Salinas, T. R. W., Gosselin, A., Planas, D., Shacklett, B. L., Cohen, É. A., Ghali, M. P., Routy, J., & Ancuța, P. (2019) · AIDS · doi:10.1097/qad.0000000000002195 · Cited by 53
Interplay between Intrinsic and Innate Immunity during HIV Infection
Bergantz, L., Subra, F., Deprez, E., Delelis, O., & Richetta, C. (2019) · Cells · doi:10.3390/cells8080922 · Cited by 48
“In contrast, HIV-2 is not affected by SAMHD1 restriction because the accessory protein Vpx induces SAMHD1 degradation [4,41].”
BackgroundInfluentialComplement-Opsonized HIV-1 Overcomes Restriction in Dendritic Cells
Posch, W., Steger, M., Knackmuss, U., Blatzer, M., Baldauf, H., Doppler, W., White, T. E., Hörtnagl, P., Diaz‐Griffero, F., Lass‐Flörl, C., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005005 · Cited by 49
Early Vertebrate Evolution of the Host Restriction Factor Tetherin
Heusinger, E., Kluge, S. F., Kirchhoff, F., & Sauter, D. (2015) · Journal of Virology · doi:10.1128/jvi.02149-15 · Cited by 42
“TRIM5 induces the untimely uncoating of the incoming retroviral capsid (13), APOBEC3G is a deaminase introducing lethal hypermutations into the viral genome (14), SAMHD1 inhibits reverse transcription by depleting intracellular deoxynucleoside triphosphate (dNTP) pools (15, 16), and tetherin restricts the release of n…”
BackgrounddNTP pool modulation dynamics by SAMHD1 protein in monocyte-derived macrophages
Hollenbaugh, J. A., Tao, S., Lenzi, G. M., Ryu, S., Kim, D., Diaz‐Griffero, F., Schinazi, R. F., & Kim, B. (2014) · Retrovirology · doi:10.1186/preaccept-5624405321277583 · Cited by 41
Vpx is Critical for SIVmne infection of pigtail macaques
Belshan, M., Kimata, J. T., Brown, C. R., Cheng, X., McCulley, A., Larsen, A., Thippeshappa, R., Hodara, V. L., Giavedoni, L. D., Hirsch, V. M., et al. (2012) · Retrovirology · doi:10.1186/1742-4690-9-32 · Cited by 45
“Since recent studies demonstrated that SAMHD1 is a cellular restriction factor for HIVs and SIVs in myeloid cells, whose stability is regulated by DCAF1 and Vpx [22,23], we assessed the stability of FLAG-tagged SAMHD1 in the presence of wild type and mutant SIV Vpx proteins (Figure 8).”
BackgroundContribution of oligomerization to the anti-HIV-1 properties of SAMHD1
Brandariz-Núñez, A., Valle‐Casuso, J. C., White, T. E., Nguyen, L. A., Bhattacharya, A., Wang, Z., Demeler, B., Amie, S. M., Knowlton, C., Kim, B., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-131 · Cited by 41
“Mechanistic studies have suggested that Vpx induces the proteasomal degradation of SAMHD1 [20-22].”
BackgroundValle‐Casuso, J. C., Allouch, A., David, A., Lenzi, G. M., Studdard, L. R., Barré‐Sinoussi, F., Müller-Trutwin, M. C., Kim, B., Pancino, G., & Sáez‐Cirión, A. (2017) · Journal of Virology · doi:10.1128/jvi.01324-17 · Cited by 44
“Although SAMHD1 is expressed in both cycling and noncycling cells, its antiviral activity only occurs in the latter (10, 12, 14, 16, 23, 56).”
Lin, A. Z., & Balazs, A. B. (2018) · Retrovirology · doi:10.1186/s12977-018-0449-7 · Cited by 42
Li, D., Lopez, A., Sandoval, C., Doyle, R. N., & Fregoso, O. I. (2020) · mBio · doi:10.1128/mbio.00940-20 · Cited by 47
“This is analogous to the degradation of SAMHD1 by lentiviral Vpx/Vpr (5, 81, 82) and could help to explain why Vpr from HIV-2, which encodes both Vpr and the paralogous Vpx protein, does not attenuate host repair machinery, or recruit host DDR proteins (6, 36, 37, 40, 41, 83), as efficiently as HIV-1 Vpr.”
MethodThe Interplay between Viruses and Host DNA Sensors
Huérfano, S., Šroller, V., Bruštíková, K., Horníková, L., & Forstová, J. (2022) · Viruses · doi:10.3390/v14040666 · Cited by 43
“SAMHD1 Depletes cellular pools of deoxynucleotide triphosphates Down regulate DNA immune sensing by affecting the availability of deoxynucleotides for reverse transcription [198,201]”
BackgroundMicroRNA-181 expression regulates specific post-transcriptional level of SAMHD1 expression in vitro
Jin, C., Peng, X., Liu, F., Cheng, L., Lu, X., Yao, H., Wu, H., & Wu, N. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.151 · Cited by 41
Su, B., Biedma, M. E., Lederle, A., Peressin, M., Lambotin, M., Proust, A. M., Decoville, T., Schmidt, S., Laumond, G., & Moog, C. (2014) · Journal of Virology · doi:10.1128/jvi.03057-13 · Cited by 43
“SAMHD1 was identified as one of several cellular restriction factors, the expression of which prevents HIV-1 reverse transcription in myeloid DCs (3, 4).”
BackgroundWang, X., Li, C., Zhou, L., Zhang, N., Wang, X., Ge, X., Guo, X., & Yang, H. (2014) · Virus Research · doi:10.1016/j.virusres.2014.07.025 · Cited by 41
mi RNA s and HIV : unforeseen determinants of host‐pathogen interaction
Swaminathan, S., Murray, D. D., & Kelleher, A. D. (2013) · Immunological Reviews · doi:10.1111/imr.12077 · Cited by 43
“The SIV accessory protein, Vpx, inhibits the action of SAMHD1 by targeting it for degradation and can be used to increase HIV-1 infection of human macrophages (56, 117).”
BackgroundStillman, B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312901110 · Cited by 36
Cyclin D3-dependent control of the dNTP pool and HIV-1 replication in human macrophages
Ruiz, A., Pauls, E., Badía, R., Torres‐Torronteras, J., Riveira‐Muñoz, E., Clotet, B., Martí, R., Ballana, E., & Esté, J. A. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1030558 · Cited by 41
Szaniawski, M. A., Spivak, A. M., Cox, J. E., Catrow, J. L., Hanley, T. M., Williams, E. S. C. P., Tremblay, M. J., Bosque, A., & Planelles, V. (2018) · mBio · doi:10.1128/mbio.00819-18 · Cited by 41
Deficiency for SAMHD1 activates MDA5 in a cGAS/STING-dependent manner
Schumann, T., Ramon, S. C., Schubert, N., Mayo, M. A., Hega, M., Maser, K. I., Ada, S.-R., Sydow, L., Hajikazemi, M., Badstübner, M., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20220829 · Cited by 45
“Through this activity, SAMHD1 limits the availability of dNTPs in resting cells, which hinders replication of pathogens like retroviruses that depend on cellular dNTP supply (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundEndogenous retroelements and autoimmune disease
Stetson, D. B. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.09.007 · Cited by 45
“Current Opinion in Immunology 2012, 24:692–697 two groups reported that SAMHD1 is an essential HIV restriction factor in human myeloid cells [32 ,33 ].”
BackgroundEstablishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+T CellsIn Vitro
Zerbato, J. M., Serrao, E., Lenzi, G. M., Kim, B., Ambrose, Z., Watkins, S. C., Engelman, A., & Sluis‐Cremer, N. (2016) · Journal of Virology · doi:10.1128/jvi.00553-16 · Cited by 51
“SAMHD1 has also been identified as an effective restriction factor to HIV-1 infection in resting CD4 T cells by enzymatically decreasing cellular dNTP pools and impeding HIV-1 reverse transcription (22, 49, 51, 78).”
BackgroundMacrophages: Key Cellular Players in HIV Infection and Pathogenesis
Woottum, M., Yan, S., Sayettat, S., Grinberg, S., Cathelin, D., Bekaddour, N., Herbeuval, J., & Bénichou, S. (2024) · Viruses · doi:10.3390/v16020288 · Cited by 42
“…of SAMHD1 by the proteasome machinery allowing for the e ffi cient replication of these lentiviruses in myeloid cells [138,139]. and some SIVs leads to the degradation of SAMHD1 by the proteasome machinery allowing for the efficient replication of these lentiviruses in myeloid cells [138,139].”
BackgroundStructural Basis for the Antiviral Activity of BST-2/Tetherin and Its Viral Antagonism
Arias, J. F., Iwabu, Y., & Tokunaga, K. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00250 · Cited by 39
“…Stremlau et al., 2004); the bone marrow stromal antigen 2 (Neil et al., 2008; Van Damme et al., 2008; BST-2, also known as tetherin or CD317, referred to hereafter as BST-2), which is the subject of this review article; and, more recently, SAMHD1 (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundInfluentialInnate immune sensing of HIV-1 infection
Jakobsen, M. R., Olagnier, D. P., & Hiscott, J. B. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000129 · Cited by 45
TRIM5α and Species Tropism of HIV/SIV
Nakayama, E. E., & Shioda, T. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00013 · Cited by 42
Franzolin, E., Salata, C., Bianchi, V., & Rampazzo, C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.675082 · Cited by 43
Expression of HIV-1 Intron-Containing RNA in Microglia Induces Inflammatory Responses
Akiyama, H., Jalloh, S., Park, S., Lei, M., Mostoslavsky, G., & Gummuluru, S. (2020) · Journal of Virology · doi:10.1128/jvi.01386-20 · Cited by 40
“We report that while HIV-1 infection of MDMGs is attenuated, restriction to infection was alleviated upon SAM domain and HD domain-containing protein 1 (SAMHD1) degradation.”
MethodInfluentialPilakka‐Kanthikeel, S., Raymond, A., Atluri, V. S. R., Sagar, V., Saxena, S. K., Diaz, P., Chevelon, S., Concepcion, M., & Nair, M. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0285-9 · Cited by 44
“This is in accordance with the previous reports in resting CD4 T cells and myeloid cells explaining that SAMHD1 is responsible for the efficient reverse transcription [27,34,35].”
BackgroundResultInfluentialAlbershardt, T. C., Campbell, D. J., Parsons, A. J., Slough, M. M., ter Meulen, J., & Berglund, P. (2016) · Molecular Therapy - Oncolytics · doi:10.1038/mto.2016.10 · Cited by 38
TMEFF1 is a neuron-specific restriction factor for herpes simplex virus
Dai, Y., Idorn, M., Serrero, M. C., Pan, X., Thomsen, E. A., Narita, R., Maimaitili, M., Qian, X., Iversen, M. B., Reinert, L. S., et al. (2024) · Nature · doi:10.1038/s41586-024-07670-z · Cited by 38
“There are several examples in the literature of RFs using more than one mechanism to restrict viral replication 35–40 .”
Early host defense against virus infections
Paludan, S. R., Pradeu, T., Pichlmair, A., Wray, K. B., Mikkelsen, J. G., Olagnier, D. P., & Mogensen, T. H. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115070 · Cited by 40
Dragin, L., Nguyen, L. A., Lahouassa, H., Sourisce, A., Kim, B., Ramírez, B. C., & Margottin-Goguet, F. (2013) · Retrovirology · doi:10.1186/1742-4690-10-30 · Cited by 39
Yang, S., Zhan, Y., Zhou, Y., Jiang, Y., Zheng, X., Yu, L., Tong, W., Gao, F., Li, L., Huang, Q., et al. (2016) · Scientific Reports · doi:10.1038/srep29665 · Cited by 43
“The JAK family phosphorylate the substrate proteins, signal transducers and activators of transcription (STAT) 1 and 2.”
Roles of SAMHD1 in antiviral defense, autoimmunity and cancer
Li, M., Zhang, D., Zhu, M., Shen, Y., Wei, W., Ying, S., Korner, H., & Li, J. (2017) · Reviews in Medical Virology · doi:10.1002/rmv.1931 · Cited by 37
“containing protein 1 (SAMHD1) has been identified and is now the subject of intense research.(4,5) The SAMHD1 was originally discovered in human dendritic cells as the homologue of a mouse IFN‐γ–induced protein and named dendritic cell‐derived IFN‐γ–induced protein (DCIP).”
BackgroundHIV-1 Is a Poor Inducer of Innate Immune Responses
Cingöz, O., & Goff, S. P. (2019) · mBio · doi:10.1128/mbio.02834-18 · Cited by 40
“role of SAMHD1 in inhibiting reverse transcription (23, 24).”
BackgroundAn Intronic G Run within HIV-1 Intron 2 Is Critical for Splicing Regulation of vif mRNA
Widera, M., Erkelenz, S., Hillebrand, F., Krikoni, A., Widera, D., Kaisers, W., Deenen, R., Gombert, M., Dellen, R., Pfeiffer, T., et al. (2012) · Journal of Virology · doi:10.1128/jvi.02755-12 · Cited by 39
Humbert, J.-M., Frecha, C. A., Amirache, F., N′Guyen, T. H., Boni, S., Cosset, F., Verhoeyen, E., & Halary, F. A. (2012) · Journal of Virology · doi:10.1128/jvi.06283-11 · Cited by 38
Sabbatucci, M., Covino, D. A., Purificato, C., Mallano, A., Federico, M., Lu, J. N., Rinaldi, A. O., Pellegrini, M. A., Bona, R., Michelini, Z., et al. (2015) · Retrovirology · doi:10.1186/s12977-014-0132-6 · Cited by 41
“Since it has been shown that SIV-Vpx induces proteasomal degradation of SAMHD1 [30,31], we utilized an HIV-1 based lentiviral vector (LV) containing SIV-Vpx and expressing GFP (LV/Vpx) to knock-down SAMHD1 and then compare LV/Vpx infected MDM treated with”
Kueck, T., Cassella, E., Holler, J. M., Kim, B., & Bieniasz, P. D. (2018) · eLife · doi:10.7554/elife.38867 · Cited by 39
HIV-1 Vpr mediates the depletion of the cellular repressor CTIP2 to counteract viral gene silencing
Forouzanfar, F., Ali, S., Wallet, C., Rovere, M. D., Ducloy, C., Mekdad, H. E., Maassarani, M. E., Aït-Ammar, A., Assche, J. V., Boutant, E., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48689-x · Cited by 45
Levesque, S., Cosentino, A., Verma, A., Genovese, P., & Bauer, D. E. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02266-4 · Cited by 41
“SAMHD1 is a triphosphohydrolase enzyme that depletes deoxyribonucleoside triphosphates (dNTPs) and acts as an antiviral factor to restrict HIV-1 infection 7–9 .”
Wijewardana, V., Kristoff, J., Xu, C., Ma, D., Haret-Richter, G. S., Stock, J. L., Policicchio, B. B., Mobley, A. D., Nusbaum, R. J., Aamer, H., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003600 · Cited by 37
“(iv) SIVagmSab does not have a vpx gene and therefore cannot infect dendritic cells because of the SAMHD1 restriction [64], as documented in our study that failed to identify viral DNA in sorted mDCs from SIVagmSabinfected PTMs, AGMs and RMs.”
ResultMaudet, C., Sourisce, A., Dragin, L., Lahouassa, H., Rain, J., Bouaziz, S., Ramírez, B. C., & Margottin-Goguet, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077320 · Cited by 37
“For example, the antiviral activity of the SAMHD1 restriction factor can only be unravelled in quiescent cells, where its viral counterpart, Vpx, enhances HIV-1 transduction [2,7,8].”
BackgroundSAMHD1-Dependent and -Independent Functions of HIV-2/SIV Vpx Protein
Fujita, M., Nomaguchi, M., Adachi, A., & Otsuka, M. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00297 · Cited by 37
“HIV-2/SIV Vpx protein”
BackgroundBallana, E., Badía, R., Terradas, G., Torres‐Torronteras, J., Ruiz, A., Pauls, E., Riveira‐Muñoz, E., Clotet, B., Martí, R., & Esté, J. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03145-14 · Cited by 42
“Reverse transcriptase was performed using the high-capacity cDNA reverse transcription kit (Life Technologies). mRNA relative levels of SAMHD1 were measured by two-step quantitative RT-PCR and normalized to GAPDH mRNA expression using the threshold cycle ( CT) method.”
BackgroundInfluentialThe G1/S Specific Cyclin D2 Is a Regulator of HIV-1 Restriction in Non-proliferating Cells
Badía, R., Pujantell, M., Riveira‐Muñoz, E., Puig, T., Torres‐Torronteras, J., Martí, R., Clotet, B., Ampudia, R. M., Vives‐Pi, M., Esté, J. A., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005829 · Cited by 39
Boso, G., & Kozak, C. A. (2020) · Microorganisms · doi:10.3390/microorganisms8121965 · Cited by 38
The Deubiquitinase USP29 Promotes SARS-CoV-2 Virulence by Preventing Proteasome Degradation of ORF9b
Gao, W., Wang, L., Ju, X., Zhao, S., Li, Z., Su, M., Xu, J., Wang, P., Ding, Q., Lv, G., et al. (2022) · mBio · doi:10.1128/mbio.01300-22 · Cited by 37
Innate Sensing of Foamy Viruses by Human Hematopoietic Cells
Rua, R., Lepelley, A., Gessain, A., & Schwartz, O. (2011) · Journal of Virology · doi:10.1128/jvi.06235-11 · Cited by 37
“Monocyte-derived DCs are poorly sensitive to HIV-1 infection due to the presence of the SAMHD1 restriction factor (31, 37).”
BackgroundSelf-citationKajaste‐Rudnitski, A., & Naldini, L. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.036 · Cited by 40
“70,75 Although HIV-1 can replicate in macrophages, addition of Vpx significantly improves infectivity, confirming a functional role for SAMHD1 also in these cells.”
Boasso, A. (2013) · Scientifica · doi:10.1155/2013/580968 · Cited by 46
“SAMHD1 is expressed at constitutively high levels by cells which are nonpermissive with regards to HIV-1 infection, such as monocytes and monocyte-derived DC [271].”
BackgroundYao, Z., Jia, X., Megger, D. A., Chen, J., Liu, Y., Li, J., Sitek, B., & Yuan, Z. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00514 · Cited by 37
Cell-to-Cell Spreading of HIV-1 in Myeloid Target Cells Escapes SAMHD1 Restriction
Xie, M., Leroy, H., Mascarau, R., Woottum, M., Dupont, M., Ciccone, C., Schmitt, A., Raynaud‐Messina, B., Vérollet, C., Bouchet, J., et al. (2019) · mBio · doi:10.1128/mbio.02457-19 · Cited by 38
“While HIV-1 infection of these myeloid cells by cell-free viruses is known to be strongly restricted (28, 63), this new mechanism of virus spreading in myeloid cells by cell fusion escapes the restriction imposed by SAMHD1 and leads to the formation of highly virus-productive MGCs reminiscent of…”
Kodigepalli, K. M., Bonifati, S., Tirumuru, N., & Wu, L. J. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1480218 · Cited by 36
Masters of manipulation: Viral modulation of the immunological synapse
Bayliss, R. J., & Piguet, V. (2018) · Cellular Microbiology · doi:10.1111/cmi.12944 · Cited by 37
Innate immune interferon responses to Human immunodeficiency virus‐1 infection
Hughes, R. W., Towers, G. J., & Noursadeghi, M. (2012) · Reviews in Medical Virology · doi:10.1002/rmv.1708 · Cited by 42
“Another gene defect associated with AGS is that of SAMHD1, that is also expressed in myeloid cells and recently been shown to mediate post-entry restriction of HIV-1 by targeting viral reverse transcription products [80,81].”
BackgroundRole of myeloid cells in HIV-1-host interplay
Stevenson, M. (2014) · Journal of NeuroVirology · doi:10.1007/s13365-014-0281-3 · Cited by 36
“The cellular restriction that is targeted by vpx was recently identified as SAMHD1 (Laguette et al. 2011; Hrecka et al. 2011).”
BackgroundGene Therapy Strategies to Exploit TRIM Derived Restriction Factors against HIV-1
Chan, E., Towers, G. J., & Qasim, W. (2014) · Viruses · doi:10.3390/v6010243 · Cited by 42
Type I Interferons as Ambiguous Modulators of Chronic Inflammation in the Central Nervous System
Prinz, M., & Knobeloch, K.-P. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00067 · Cited by 35
“Two recent publications identified SAMHD1 as the factor restricting HIV infection in myeloid and dendritic cells and showed that Vpx proteins counteract this restriction by mediating proteasomal degradation of SAMHD1 (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundSAMHD1 Limits HIV-1 Antigen Presentation by Monocyte-Derived Dendritic Cells
Ayinde, D., Bruel, T., Cardinaud, S., Porrot, F., Prado, J. G., Moris, A., & Schwartz, O. (2015) · Journal of Virology · doi:10.1128/jvi.00069-15 · Cited by 36
“In any case, inhibition of SAMHD1 enhances productive infection of DCs by cell-free and cell-associated HIV-1 (8, 14).”
BackgroundMethodSelf-citationMiazzi, C., Ferraro, P., Pontarin, G., Rampazzo, C., Reichard, P. A., & Bianchi, V. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.571091 · Cited by 41
“Interest in the protein exploded in recent years, when it was discovered that the enzyme via its phosphohydrolase activity (1, 2) serves as a restriction factor during HIV-1 infection (3, 4).”
BackgroundSAMHD1: a new contributor to HIV-1 restriction in resting CD4+T-cells
Wu, L. J. (2012) · Retrovirology · doi:10.1186/1742-4690-9-88 · Cited by 37
“SAMHD1 is primarily a nuclear protein [5,8] that has a nuclear localization signal in the N-terminus [11].”
InfluentialMlčochová, P., Winstone, H., Zuliani‐Alvarez, L., & Gupta, R. K. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.03.008 · Cited by 37
BCA2/Rabring7 Targets HIV-1 Gag for Lysosomal Degradation in a Tetherin-Independent Manner
Nityanandam, R., & Serra-Moreno, R. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004151 · Cited by 36
“These include APOBEC3 proteins, TRIM5 members, Mx2/MxB, SAMHD1 and tetherin/BST2 [5,6,8,9,10,11,14,15, 16,17,18,19,41].”
BackgroundVpr Enhances Tumor Necrosis Factor Production by HIV-1-Infected T Cells
Roesch, F., Richard, L., Rua, R., Porrot, F., Casartelli, N., & Schwartz, O. (2015) · Journal of Virology · doi:10.1128/jvi.02098-15 · Cited by 37
“and HIV-2 Vpx, by degrading SAMHD1 (15, 16), promotes infec-”
BackgroundSelf-citationFunctional Analysis of the Relationship between Vpx and the Restriction Factor SAMHD1
Berger, G., Turpin, J., Cordeil, S., Tartour, K., Nguyen, X.-N., Mahieux, R., & Cimarelli, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.403816 · Cited by 35
HIV replication: a game of hide and sense
Sauter, D., & Kirchhoff, F. (2015) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000233 · Cited by 43
“The accessory protein Vpr and its paralog Vpx of HIV-2 and many SIVs degrade the restriction factor SAMHD1 [45,46,90].”
BackgroundCell-to-Cell Spread of HIV and Viral Pathogenesis
Law, K., Satija, N., Esposito, A. M., & Chen, B. K. (2016) · Advances in virus research · doi:10.1016/bs.aivir.2016.03.001 · Cited by 39
“Low infection rates have been attributed to low levels of expression of CD4 and coreceptor, degradation of HIV, and abundance of restriction factors (Laguette et al., 2011).”
BackgroundWhite, T. E., Brandariz-Núñez, A., Martínez‐López, A., Knowlton, C., Lenzi, G. M., Kim, B., Ivanov, D. N., & Diaz‐Griffero, F. (2017) · Human Mutation · doi:10.1002/humu.23201 · Cited by 37
“Because Vpx triggers the degradation of SAMHD1 (Hrecka et al., 2011; Laguette et al., 2011), we tested the ability of Vpx to induce the degradation of the different human SAMHD1 proteins.”
BackgroundMethodInfluentialVirion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells
Miller, C. M., Akiyama, H., Agosto, L. M., Emery, A., Ettinger, C. R., Swanstrom, R. I., Henderson, A. J., & Gummuluru, S. (2017) · Journal of Virology · doi:10.1128/jvi.00051-17 · Cited by 38
“HIV-1 replication in MDDCs is restricted at the reverse transcription (RT) step by SAMHD1, which controls the size of cytosolic deoxynucleoside triphosphate (dNTP) pools (51, 52).”
BackgroundUSP18 (UBP43) Abrogates p21-Mediated Inhibition of HIV-1
Kuffour, E. O., Schott, K., Vasudevan, A. A. J., Holler, J. M., Schulz, W. A., Lang, P. A., Lang, K. S., Kim, B., Häussinger, D., König, R., et al. (2018) · Journal of Virology · doi:10.1128/jvi.00592-18 · Cited by 37
Detailed Characterization of Early HIV-1 Replication Dynamics in Primary Human Macrophages
Bejarano, D. A., Puertas, M. C., Börner, K., Martínez‐Picado, J., Müller, B., & Kräusslich, H. (2018) · Viruses · doi:10.3390/v10110620 · Cited by 37
“The triphosphohydrolase activity of the host protein SAMHD1 is important for maintaining low dNTP levels in macrophages, and the protein was recognized as an important host cell restriction factor of HIV-1 infection [23].”
BackgroundLentiviral Vector-Based Dendritic Cell Vaccine Suppresses HIV Replication in Humanized Mice
Norton, T. D., Zhen, A., Tada, T., Kim, J. S., Kitchen, S. G., & Landau, N. R. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.03.008 · Cited by 35
Hypoxia-induced human deoxyribonuclease I is a cellular restriction factor of hepatitis B virus
Hallez, C., Li, X., Suspène, R., Thiers, V., Bouzidi, M. S., Dorobantu, C. M., Lučanský, V., Wain–Hobson, S., Gaudin, R., & Vartanian, J. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0405-x · Cited by 35
Metadata
- Authors
- Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Laguette, Nadine
- Benkirane, Monsef
- ORCID
- Venue
- Nature
- Published
- 2011-05-25
- Volume
- 474
- Issue
- 7353
- Pages
- 654-657
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3595993
- OpenAlex
- W2069554621
- Cited by
- 1,511
- References
- 27
- Citations by year
- 2026: 45 · 2025: 60 · 2024: 67 · 2023: 67 · 2022: 84 · 2021: 72 · 2020: 82 · 2019: 113 · 2018: 113 · 2017: 109 · 2016: 114 · 2015: 118 · 2014: 134 · 2013: 159 · 2012: 131
- FWCI
- 58.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- SAMHD1, HIV-1 restriction factors, Vpx, dendritic cells, myeloid cells, Aicardi-Goutières syndrome, proteasomal degradation, HIV-1 replication, viral DNA accumulation, phosphohydrolase activity, interferon response, HIV-2, simian immunodeficiency virus
- MeSH terms
- SAM Domain and HD Domain-Containing Protein 1, Cell Line, Dendritic Cells, DNA, Viral, HeLa Cells, Humans, Virus Replication, HIV-1, HIV Infections, U937 Cells, Monomeric GTP-Binding Proteins, Gene Silencing, Myeloid Cells, Proteasome Endopeptidase Complex, Viral Regulatory and Accessory Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.